The legal library gives you easy access to the FTC’s case information and other official legal, policy, and guidance documents.
Granting of Request for Early Termination of the Waiting Period Under the Premerger Notification Rules
Getinge AB and Databascope Corp.; Analysis of Agreement containing Consent Order to Aid Public Comment
0902001 Informal Interpretation
Applicability of the "Red Flags" Rule to Health Care Providers
Franciscan Missionaries of Our Lady Health System, Inc./Cappella Healthcare Inc.
Independent Physicians Associates Medical Group, Inc., d/b/a AllCare IPA, In the Matter of
The Commission challenged the conduct of AllCare IPA, alleging that AllCare restrained competition in fee-for-service contracts by fixing prices and other contract terms with payers, engaging in collective negotiations over the terms and conditions of dealing with payers, and preventing group members from negotiating with payers except on terms approved by All Care. The Commission issued a consent order prohibiting All Care from entering into agreements between or among physicians: 1) to negotiate on behalf of any physician with any payer; 2) to refuse to deal, or threaten to refuse to deal, with any payer; 3) to designate the terms, conditions, or requirements upon which any physician deals, or is willing to deal, with any payer, including, but not limited to price terms; 4) not to deal individually with any payer, or not to deal with any payer through any arrangement other than one involving All Care.
King Pharmaceuticals, Inc., and Alpharma Inc., In the Matter of
In late 2008, the Commission issued a consent order to restore competition in the market for oral long-acting opioids (LAOs). The FTC intervened in King Pharmaceutical’s proposed $1.6 billion acquisition of rival drug-maker Alpharma Inc. because the transaction would have joined the two leading producers of morphine sulfate oral LAO’s in the United States, a market which was already highly concentrated and which had annual sales of $4 billion in 2007. In order to maintain competition in the market, the Commission’s consent order requires King to divest its Kadian business to Actavis, a company which already manufactured the drug for King, and which could then produce a generic equivalent of the drug sooner than would have been permitted under King’s patent, which would not have expired until 2010.
0902002 Informal Interpretation
0902003 Informal Interpretation
0901006 Informal Interpretation
Guides Concerning the Use of Testimonials in Advertising - 16 CFR Part 255
Concurring Statement of Commissioner Jon Leibowitz In re Federal Trade Commission v. Watson Pharmaceuticals et. Al.
Dow Chemical Company; Analysis of Agreement Containing Consent Orders to Aid Public Comment
0901008 Informal Interpretation
CRH plc, Oldcastle, Inc., Oldcastle Architectural, Inc., Robert Schlegel, and Pavestone Company, L.P., In the Matter of
The Commission issued an administrative complaint to challenge Oldcastle Architectural’s (a subsidiary of CRH) proposed $540 million acquisition of Pavestone Companies as anticompetitive in the US market for drycast concrete hardscape products sold to retailers such as The Home Depot, Lowe’s, and Wal-Mart Stores. According to the complaint, the acquisition would reduce competition by combining the only two companies capable of the national manufacture and sale of these heavy products, which include concrete pavers, segmented retaining wall blocks, and concrete patio products, due to the difficulty in distribution of such products, and the fact that both Oldcastle and Pavestone already possess large distribution networks. The acquisition as proposed would result in Oldcastle gaining a 90% market share for the manufacture and sale of these drycast products to home centers in the United States. The Commission also authorized staff to file a complaint in federal court seeking a temporary restraining order and preliminary injunction to prevent consummation of the proposed transaction, but the respondents decided not to proceed with the proposed merger and the Commssion dismissed the administrative complaint.